Norges Bank’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41M | Buy |
+2,367,224
| New | +$41M | 0.01% | 1024 |
|
|
2025
Q1 | – | Sell |
-1,086,243
| Closed | -$34.7M | – | 111 |
|
|
2024
Q4 | $34.7M | Buy |
+1,086,243
| New | +$34.7M | ﹤0.01% | 1102 |
|
|
2024
Q3 | – | Sell |
-1,079,605
| Closed | -$41.4M | – | 114 |
|
|
2024
Q2 | $41.4M | Buy |
1,079,605
+71,685
| +7% | +$2.75M | 0.01% | 974 |
|
|
2024
Q1 | $59.2M | Buy |
1,007,920
+61,707
| +7% | +$3.63M | 0.01% | 857 |
|
|
2023
Q4 | $56.6M | Sell |
946,213
-105,980
| -10% | -$6.34M | 0.01% | 847 |
|
|
2023
Q3 | $40M | Buy |
1,052,193
+29,167
| +3% | +$1.11M | 0.01% | 940 |
|
|
2023
Q2 | $93.2M | Buy |
1,023,026
+91,516
| +10% | +$8.34M | 0.02% | 600 |
|
|
2023
Q1 | $61.4M | Sell |
931,510
-115,944
| -11% | -$7.65M | 0.01% | 742 |
|
|
2022
Q4 | $54.2M | Buy |
1,047,454
+74,480
| +8% | +$3.85M | 0.01% | 777 |
|
|
2022
Q3 | $66.5M | Buy |
972,974
+27,094
| +3% | +$1.85M | 0.02% | 656 |
|
|
2022
Q2 | $42.8M | Buy |
945,880
+130,915
| +16% | +$5.92M | 0.01% | 844 |
|
|
2022
Q1 | $41.4M | Buy |
814,965
+174,798
| +27% | +$8.88M | 0.01% | 987 |
|
|
2021
Q4 | $30.3M | Buy |
640,167
+129,989
| +25% | +$6.15M | 0.01% | 1225 |
|
|
2021
Q3 | $16.8M | Buy |
510,178
+68,317
| +15% | +$2.25M | ﹤0.01% | 1582 |
|
|
2021
Q2 | $27.9M | Sell |
441,861
-71,189
| -14% | -$4.5M | 0.01% | 1325 |
|
|
2021
Q1 | $22M | Sell |
513,050
-149,647
| -23% | -$6.42M | 0.01% | 1489 |
|
|
2020
Q4 | $37.9M | Buy |
662,697
+19,906
| +3% | +$1.14M | 0.01% | 1164 |
|
|
2020
Q3 | $19.4M | Buy |
642,791
+538,104
| +514% | +$16.2M | 0.01% | 1443 |
|
|
2020
Q2 | $3.42M | Sell |
104,687
-280,313
| -73% | -$9.15M | ﹤0.01% | 1909 |
|
|
2020
Q1 | $10.3M | Buy |
+385,000
| New | +$10.3M | ﹤0.01% | 1601 |
|
|
2018
Q2 | – | Sell |
-75,000
| Closed | -$1.66M | – | 2129 |
|
|
2018
Q1 | $1.66M | Hold |
75,000
| – | – | ﹤0.01% | 2017 |
|
|
2017
Q4 | $1.63M | Buy |
+75,000
| New | +$1.63M | ﹤0.01% | 2002 |
|